His decision came as an investigation into sexual harassment allegations against him was ongoing.
The Scientist brings together a panel of experts to discuss emerging technologies for disease modeling in regenerative medicine and stem cell therapy.
February 16, 2016|
Cell-based model systems are powerful tools for studying signaling pathways, deciphering disease mechanisms, and predicting drug activities. Advances in stem cell technology provide new opportunities for in vitro modeling and screening in a physiologically relevant environment that is consistent and replicable. The Scientist brings together a panel of experts to discuss emerging technologies for disease modeling in regenerative medicine and stem cell therapy. Attendees will have an opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.
Dr. Doo Yeon Kim
Assistant Professor of Neurology
Genetics and Aging Research Unit
Massachusetts General Hospital
Harvard Medical School
Dr. Jason Spence
Department of Internal Medicine, Gastroenterology
Department of Cell and Developmental Biology
University of Michigan